Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Session 3 - Expanding Theranostics to Prostate Cancer

Biology in Advanced Prostate Cancer with a Special Focus on PSMA across the Disease Spectrum (Primary Tumour, Upregulation with AR Targeted Therapies, Heterogeneity, ...)


22 May 2024


Session 3 - Expanding Theranostics to Prostate Cancer


Nuclear Medicine and Clinical Molecular Imaging;  Therapy

Tumour Site

Prostate Cancer


E. Compérat, AT


This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.